TARGETING THE TWIST1/HOXA9 AXIS TO INDUCE PARP INHIBITION TREATMENT SENSITIZATION AND SYNTHETIC LETHALITY IN LUNG CANCER CELLS

The Johns Hopkins University

Investigators